An examination of known chromosomal anomalies of the CLL populations under study (Table 1) reveals other factors complicating our assessment of how miR15a/miR16-1 loss affects BCL2 (and MCL1) expression. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.